AR and urinary bladder cancer: An increase or a decrease in cisplatin cytotoxicity via inactivation (e.g., anti-androgen treatment, AR knockdown) [70,102] or overexpression [103] of AR in bladder cancer cells has been confirmed in more recent studies.